Abstract
PerkinElmer has developed assay technologies, microplates, multi-mode plate readers and Imaging instrumentation + reagents for Drug Discovery research. The HTRF and AlphaLISA homogeneous, orthogonal assay platforms are robust, flexible and can be applied to a large range of drug targets within Infection Biology for small and large molecule drug research. This presentation highlights:
Homogeneous assays for:
viral antigen quantification
detecting immune-response e.g. cytokine release + phospho-protein signalling assays
virus:host interaction e.g. Biochemical PPI assays for COVID-19 therapeutic discovery
anti-viral antibodies
Cell-based strategies for:
Britelite Plus Luciferase viral neutralisation assays
ATPlite luminescence viral cytopathic effect assays (CPE)
PhenoVue Cellular Imaging Reagents + Phenoplate microplates (HCS)